Perrigo Company plc Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
Perrigo Company plc (PRGO) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $1.40 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-28.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2023-02-28
- Perrigo Company plc noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2020 was $1.40M.
- Perrigo Company plc noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2014 was $7.20M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|
| 2020-12-31 | $1.40M 10-K · filed 2023-02-28 |
| 2014-06-28 | $7.20M 10-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |